North America Cancer Vaccines Market Research Report 2020-2027

Dublin, Nov. 27, 2020 (GLOBE NEWSWIRE) -- The "North America Cancer Vaccines Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Technology; Type; Indication; End User, and Country" report has been added to ResearchAndMarkets.com's offering.

Cancer Vaccines Market for Dendritic Cells Cancer Vaccines Segment to Grow at Fastest CAGR during Forecast Period

The market is expected to reach US$6,626.6 million in 2027 from US$1,875.7 million in 2019; it is estimated to grow at a CAGR of 17.5% from 2020 to 2027.

Based on technology, the Cancer Vaccines market is segmented into in dendritic cells cancer vaccines, recombinant cancer vaccines, antigen cancer vaccines, whole cell cancer vaccines, viral vector cancer vaccines. The in recombinant cancer vaccines segment held the largest share of the market in 2019. Moreover, recombinant cancer vaccines is estimated grow at the highest CAGR in the market during the forecast period.

The North America Cancer Vaccines market growth is mainly attributed to factors such as growing prevalence of cancer, and rising government initiatives to prevent it. However, the challenges in cancer vaccines industry like expensive cost restrains the growth of the market.

AstraZeneca, GlaxoSmithKline plc., Aduro Biotech Inc, Pfizer Inc., Sanofi, Bristol-Myers Squibb, Moderna, Inc., OncBioMune Pharmaceuticals Inc., MaxiVAX, Nouscom are among the leading companies operating in the Cancer Vaccines Market.

Key Topics Covered:

1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation

2. Cancer Vaccines Market - Key Takeaways

3. Research Methodology

4. Cancer Vaccines - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinion

5. North America Cancer Vaccines Market - Industry Dynamics
5.1 Key Drivers
5.1.1 Increase in Prevalence of Cancer Worldwide
5.1.2 Initiatives Taken by Global Health Research Organizations and Key Players for Cancer Vaccines
5.2 Key Market Restraints
5.2.1 Less Number of Commercially Available Vaccines for Treatment of Cancer
5.2.2 Higher Cost of Cancer Vaccines
5.3 Key Market Opportunities
5.3.1 Increasing Government support in Emerged Countries
5.4 Future Trends
5.4.1 Growing Research and Development Activities
5.5 Impact analysis

6. Cancer Vaccines Market - Regional Analysis
6.1 North America Cancer Vaccines Market Revenue Forecast And Analysis

7. North America Cancer Vaccines Market Analysis - By Technology
7.1 Overview
7.2 Cancer Vaccines Market Share, by Technology, 2019 and 2027 (%)
7.3 Dendritic Cells Cancer Vaccine
7.5 Recombinant Cancer Vaccines
7.6 Antigen Cancer Vaccines
7.7 Whole Cell Cancer Vaccines
7.8 Viral Vector Cancer Vaccines

8. Cancer Vaccines Market Analysis - By Type
8.1 Overview
8.2 Cancer Vaccines Market Revenue Share, by Type (2019 and 2027)
8.3 Preventive Cancer Vaccines
8.4 Therapeutic Cancer Vaccines

9. Cancer Vaccines Market Analysis - By Indication
9.1 Overview
9.2 Cancer Vaccines Market Revenue Share, by Indication (2019 and 2027)
9.3 Cervical Cancer
9.4 Prostate Cancer

10. Cancer Vaccines Market Analysis - By End Use
10.1 Overview
10.2 Cancer Vaccines Market Revenue Share, by End Use (2019 and 2027)
10.3 Pediatrics
10.4 Adults

11. Cancer Vaccines Market - Geographic Analysis

12. Impact Of COVID-19 Pandemic On Global Cancer Vaccines Market
12.1 North America: Impact Assessment of COVID-19 Pandemic

13. Cancer Vaccines Market - Industry Landscape
13.1 Overview
13.2 Growth Strategies Done by the Companies in the Market, (%)
13.3 Organic Developments
13.4 Inorganic Developments

14. Company Profiles

• AstraZeneca

• GlaxoSmithKline plc.

• Aduro Biotech Inc

• Pfizer Inc.

• Sanofi

• Bristol-Myers Squibb

• Moderna, Inc.

• OncBioMune Pharmaceuticals Inc.

• MaxiVAX

• Nouscom

For more information about this report visit https://www.researchandmarkets.com/r/u0wh88

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

CONTACT: CONTACT: ResearchAndMarkets.com Laura Wood, Senior Press Manager press@researchandmarkets.com For E.S.T Office Hours Call 1-917-300-0470 For U.S./CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900